Imagin Medical Inc. IMEXF Archives - Page 6 of 6

ThursdayDec 31, 2020 2:55 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Eyes Expansion of Proprietary Imaging Technology

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, assists surgeons to more effectively root out cancers in a minimally invasive manner by making it possible to better see the interior recesses of men and women during medical procedures. The company will launch its platform with the introduction of the i/Blue Imaging (TM) System, a proprietary imaging technology based on advanced optics and light sensors. The value of Imagin’s platform is that it makes surgery-revolutionizing technology more available to hospitals through the ability to adapt it to existing equipment. A recent article discussing Imagin’s solution reads, “The company’s initial…

TuesdayDec 22, 2020 2:39 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Takes Game-Changing Visualization Method to the Next Level

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is at the forefront of change in its focus to establish a new standard of care in visualizing cancer. Minimally invasive surgery (“MIS”) using white light to illuminate tumor growth is the current standard of care for bladder cancer. This method is highly effective for visualizing cancerous tumors that protrude above the bladder’s wall. However, due to the difficulty in distinguishing flat tumors from normal tissue, it is nearly impossible to visualize the margins of the tumor under current standards. Game-changing to the industry has been the introduction of blue…

FridayDec 18, 2020 2:25 pm

QualityStocksNewsBreaks – Why Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Is ‘One to Watch’

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company that is focused on establishing a new standard of care in visualizing cancer. The company’s initial focus is on bladder cancer and its first product is the i/Blue Imaging(TM) System. Based on advanced optics, light sensors and employing patented ultrasensitive imaging technology, Imagin believes its system can significantly improve surgeons’ ability to visualize and remove cancer cells. A recent article discussing the company reads, “Imagin Medical’s i/Blue Imaging System addresses the limitations of both white and blue light cystoscopies. The i/Blue System combines the white and blue light with…

ThursdayDec 17, 2020 1:33 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Makes it Easier to See the Invisible in Cancer Surgery

Imagin Medical Inc. is a surgical imaging company building a platform of technological products designed to improve endoscopic surgeries through adaptable equipment that makes it easier to see anomalies such as cancerous tumors The company’s initial product launch will focus on bladder cancers visible under blue light thanks to a dye on the market that currently depends on the acquisition of expensive new equipment by hospitals Imagin’s proprietary i/Blue Imaging (TM) System resolves some of the expense and flexibility concerns expressed by urologists, which will grant surgeons the capacity to better root out cancers Imagin has announced an offering of…

MondayDec 14, 2020 1:31 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Technology to Change Current Standard of Care for Bladder Cancer Patients

The company’s proprietary technology could change the way surgeons handle cystoscopy procedures by displaying white light and blue light images side-by-side on one screen The technology is primarily promoted as an imaging device for bladder cancer but has the potential to expand to other endoscopic procedures including laparoscopic, colorectal and thoracic Bladder cancer is the sixth most prevalent cancer in the United States, with 600,000 people fearing recurrence The global market for bladder cancer is estimated to grow to an estimated $4.71 billion by 2026 The current standard of care for bladder cancer is minimally invasive surgery (MIS)uses white light…

TuesdayDec 08, 2020 1:21 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Is ‘One to Watch’

Imagin Medical Inc. uses the standard levels of care for bladder tumor resection and adds advanced technology combined with an FDA-approved imaging agent to display images side-by-side in real-time to provide better cancer visualization, potentially leading to less recurrence Hospitals can use their existing endoscopic equipment, as the company’s technology is compatible with almost every model on the market The i/Blue™ Imaging System can potentially be used for other minimally invasive procedures, accommodating multiple contrast agents and illumination sources Bladder cancer contributes to 4.5% of all new cancers diagnosed and 3% of all cancer-related deaths. It is the sixth most…

Site Search

Company Search

Tag: Imagin Medical Inc. IMEXF

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Eyes Expansion of Proprietary Imaging Technology

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Takes Game-Changing Visualization Method to the Next Level

QualityStocksNewsBreaks – Why Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Is ‘One to Watch’

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Makes it Easier to See the Invisible in Cancer Surgery

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Technology to Change Current Standard of Care for Bladder Cancer Patients

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Is ‘One to Watch’

Market Basics

Newsletter Publishers

Public Companies